73 related articles for article (PubMed ID: 11834890)
1. Relationship between prostatic alpha(1)-adrenoceptor binding and reduction in intraurethral pressure following continuous infusion of KMD-3213 in rats.
Akiyama K; Tatemichi S; Katayama S; Nakajima M; Oki T; Okura T; Yamada S; Kimura R
Pharmacology; 2002; 64(3):140-7. PubMed ID: 11834890
[TBL] [Abstract][Full Text] [Related]
2. In vivo demonstration of alpha(1A)-adrenoceptor subtype selectivity of KMD-3213 in rat tissues.
Yamada S; Okura T; Kimura R
J Pharmacol Exp Ther; 2001 Jan; 296(1):160-7. PubMed ID: 11123376
[TBL] [Abstract][Full Text] [Related]
3. In vivo receptor binding of novel alpha1-adrenoceptor antagonists for treatment of benign prostatic hyperplasia.
Yamada S; Ohkura T; Kimura R; Kawabe K
Life Sci; 1998; 62(17-18):1585-9. PubMed ID: 9585140
[TBL] [Abstract][Full Text] [Related]
4. [Duration of action of silodosin (KMD-3213) against phenylephrine-induced increase in intraurethral pressure in rats].
Kobayashi M; Tatemichi S; Kobayashi K; Imamura T; Maruyama I; Yamazaki Y; Shibata N
Yakugaku Zasshi; 2006 Mar; 126 Spec no.():231-6. PubMed ID: 16518088
[TBL] [Abstract][Full Text] [Related]
5. [Effects of silodosin (KMD-3213) on phenylephrine-induced increase in intraurethral pressure and blood pressure in rats--study of the selectivity for lower urinary tract].
Tatemichi S; Kobayashi K; Maruyama I; Kobayashi M; Yamazaki Y; Shibata N
Yakugaku Zasshi; 2006 Mar; 126 Spec no.():217-23. PubMed ID: 16518086
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.
Murata S; Taniguchi T; Muramatsu I
Br J Pharmacol; 1999 May; 127(1):19-26. PubMed ID: 10369451
[TBL] [Abstract][Full Text] [Related]
7. Effects of KMD-3213, a uroselective alpha 1A-adrenoceptor antagonist, on the tilt-induced blood pressure response in normotensive rats.
Akiyama K; Hora M; Yamagishi R; Kitazawa M
Jpn J Pharmacol; 2002 Oct; 90(2):131-7. PubMed ID: 12419883
[TBL] [Abstract][Full Text] [Related]
8. Tissue selectivity of KMD-3213, an alpha(1)-adrenoreceptor antagonist, in human prostate and vasculature.
Murata S; Taniguchi T; Takahashi M; Okada K; Akiyama K; Muramatsu I
J Urol; 2000 Aug; 164(2):578-83. PubMed ID: 10893647
[TBL] [Abstract][Full Text] [Related]
9. In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.
Noguchi Y; Ohtake A; Suzuki M; Sasamata M
Eur J Pharmacol; 2008 Feb; 580(1-2):256-61. PubMed ID: 18078926
[TBL] [Abstract][Full Text] [Related]
10. Effect of KMD-3213, an alpha 1a-adrenoceptor-selective antagonist, on the contractions of rabbit prostate and rabbit and rat aorta.
Yamagishi R; Akiyama K; Nakamura S; Hora M; Masuda N; Matsuzawa A; Murata S; Ujiie A; Kurashina Y; Iizuka K; Kitazawa M
Eur J Pharmacol; 1996 Nov; 315(1):73-9. PubMed ID: 8960867
[TBL] [Abstract][Full Text] [Related]
11. KMD-3213, a uroselective and long-acting alpha(1a)-adrenoceptor antagonist, tested in a novel rat model.
Akiyama K; Hora M; Tatemichi S; Masuda N; Nakamura S; Yamagishi R; Kitazawa M
J Pharmacol Exp Ther; 1999 Oct; 291(1):81-91. PubMed ID: 10490890
[TBL] [Abstract][Full Text] [Related]
12. [Alpha1-adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213)].
Tatemichi S; Kobayashi K; Maezawa A; Kobayashi M; Yamazaki Y; Shibata N
Yakugaku Zasshi; 2006 Mar; 126 Spec no.():209-16. PubMed ID: 16518085
[TBL] [Abstract][Full Text] [Related]
13. Effect of KMD-3213, an alpha1A-adrenoceptor antagonist, on the prostatic urethral pressure and blood pressure in male decerebrate dogs.
Akiyama K; Noto H; Nishizawa O; Sugaya K; Yamagishi R; Kitazawa M; Tsuchida S
Int J Urol; 2001 Apr; 8(4):177-83. PubMed ID: 11260350
[TBL] [Abstract][Full Text] [Related]
14. Actions of A-131701, a novel, selective antagonist for alpha-1A compared with alpha-1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity.
Hancock AA; Brune ME; Witte DG; Marsh KC; Katwala S; Milicic I; Ireland LM; Crowell D; Meyer MD; Kerwin JF
J Pharmacol Exp Ther; 1998 May; 285(2):628-42. PubMed ID: 9580607
[TBL] [Abstract][Full Text] [Related]
15. Alpha-1 adrenoceptor up-regulation induced by prazosin but not KMD-3213 or reserpine in rats.
Zhang L; Taniguchi T; Tanaka T; Shinozuka K; Kunitomo M; Nishiyama M; Kamata K; Muramatsu I
Br J Pharmacol; 2002 Apr; 135(7):1757-64. PubMed ID: 11934817
[TBL] [Abstract][Full Text] [Related]
16. Disposition and alpha(1)-adrenoceptor binding characteristics of JTH-601 and its metabolites in rat tissues.
Yamada S; Okura T; Kimura R; Deguchi Y; Suzuki Y; Kobayashi T; Aisaka K
Drug Metab Dispos; 2000 Dec; 28(12):1487-92. PubMed ID: 11095588
[TBL] [Abstract][Full Text] [Related]
17. Selective and sustained occupancy of prostatic alpha1-adrenoceptors by oral administration of KMD-3213 and its plasma concentration in rats.
Okura T; Yamada S; Abe Y; Kimura R
J Pharm Pharmacol; 2002 Jul; 54(7):975-82. PubMed ID: 12162717
[TBL] [Abstract][Full Text] [Related]
18. An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists.
Pulito VL; Li X; Varga SS; Mulcahy LS; Clark KS; Halbert SA; Reitz AB; Murray WV; Jolliffe LK
J Pharmacol Exp Ther; 2000 Jul; 294(1):224-9. PubMed ID: 10871316
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.
Nagarathnam D; Miao SW; Lagu B; Chiu G; Fang J; Murali Dhar TG; Zhang J; Tyagarajan S; Marzabadi MR; Zhang F; Wong WC; Sun W; Tian D; Wetzel JM; Forray C; Chang RS; Broten TP; Ransom RW; Schorn TW; Chen TB; O'Malley S; Kling P; Schneck K; Bendesky R; Harrell CM
J Med Chem; 1999 Nov; 42(23):4764-77. PubMed ID: 10579840
[TBL] [Abstract][Full Text] [Related]
20. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.
Nanda K; Naruganahalli KS; Gupta S; Malhotra S; Tiwari A; Hegde LG; Jain S; Sinha N; Gupta JB; Chugh A; Anand N; Ray A
Eur J Pharmacol; 2009 Apr; 607(1-3):213-9. PubMed ID: 19239913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
